248 related articles for article (PubMed ID: 8818885)
1. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.
Hallis B; James BA; Shone CC
J Clin Microbiol; 1996 Aug; 34(8):1934-8. PubMed ID: 8818885
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
3. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro.
Ekong TAN; Feavers IM; Sesardic D
Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3337-3347. PubMed ID: 9353935
[TBL] [Abstract][Full Text] [Related]
4. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
Shone CC; Roberts AK
Eur J Biochem; 1994 Oct; 225(1):263-70. PubMed ID: 7925446
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
7. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
Foran P; Shone CC; Dolly JO
Biochemistry; 1994 Dec; 33(51):15365-74. PubMed ID: 7803399
[TBL] [Abstract][Full Text] [Related]
8. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.
Schiavo G; Benfenati F; Poulain B; Rossetto O; Polverino de Laureto P; DasGupta BR; Montecucco C
Nature; 1992 Oct; 359(6398):832-5. PubMed ID: 1331807
[TBL] [Abstract][Full Text] [Related]
9. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
10. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
[TBL] [Abstract][Full Text] [Related]
12. Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins.
Jones RG; Ochiai M; Liu Y; Ekong T; Sesardic D
J Immunol Methods; 2008 Jan; 329(1-2):92-101. PubMed ID: 17976638
[TBL] [Abstract][Full Text] [Related]
13. Optimization of SNAP-25-derived peptide substrate for improved detection of botulinum A in the Endopep-MS assay.
Rosen O; Feldberg L; Dor E; Gura S; Zichel R
Anal Biochem; 2017 Jul; 528():34-37. PubMed ID: 28450105
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.
Yamasaki S; Baumeister A; Binz T; Blasi J; Link E; Cornille F; Roques B; Fykse EM; Südhof TC; Jahn R
J Biol Chem; 1994 Apr; 269(17):12764-72. PubMed ID: 8175689
[TBL] [Abstract][Full Text] [Related]
15. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
[TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of a region of vesicle associated membrane protein2 (VAMP2) gene and its use as a recombinant peptide substrate for assaying clostridial neurotoxins in contaminated biologicals.
Moghaddam MM; Mousavi L; Shokrgozar MA; Amani J; Nazariyan S; Azari S
Biologicals; 2010 Jan; 38(1):113-9. PubMed ID: 20005125
[TBL] [Abstract][Full Text] [Related]
18. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
Sikorra S; Henke T; Galli T; Binz T
J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
[TBL] [Abstract][Full Text] [Related]
19. Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B.
Szílagyi M; Rivera VR; Neal D; Merrill GA; Poli MA
Toxicon; 2000 Mar; 38(3):381-9. PubMed ID: 10669027
[TBL] [Abstract][Full Text] [Related]
20. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]